20.18USD-4.09%Mkt Cap: 889.80M $P/E: 12.161d ago
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. I…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Cheaper
P/B
Cheaper
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap889.80M $
Enterprise Value1.28B $
Revenue (TTM)720.53M $
Gross Profit356.06M $
Net Income (TTM)98.09M $
Revenue/Share15.61 USD
Last Price20.18 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS03209R1032
Valuation
P/E (Trailing)12.16
P/E (Forward)6.64
PEG—
EV/EBITDA6.51
EV/Revenue1.78
P/S1.23
P/B1.16
EPS (TTM)1.66
EPS (Forward)3.04
52W Range
16.6524% of range31.26
52W High31.26 USD
52W Low16.65 USD
Profitability
Gross Margin49.46%
Oper. Margin7.96%
EBITDA Margin27.38%
Profit Margin13.63%
ROE12.44%
ROA6.02%
Growth
Revenue Growth0.40%
Earnings Growth-72.50%
Cash Flow & Leverage
Operating CF156.12M $
CapEx (TTM)37.13M $
FCF Margin14.31%
FCF Yield11.59%
Net Debt394.43M $
Net Debt/EBITDA2.00
Balance Sheet
Debt/Equity0.83
Current Ratio3.85
Quick Ratio2.73
Book Value/Sh17.33 USD
Cash/Share6.621 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.00 USD
Upside (mean)+9.0%
Target Range19.00 USD – 30.00 USD
$19.00+9.0% to mean$30.00
# Analysts6
Ownership
Shares Out.44.09M
Float32.83M
Insiders29.74%
Institutions76.50%
Short Interest
Short Ratio5.8d
Short % Float18.03%
Short % Out.8.62%
Shares Short3.80M
Short (prev mo.)3.78M
Technical
SMA 5020.02 (+0.8%)
SMA 20023.77 (-15.1%)
Beta0.90
S&P 52W Chg20.05%
Avg Vol (30d)605.03K
Avg Vol (10d)755.07K
Technical Indicators
RSI (14)53.2
MACD0.1869
MACD Signal0.0282
MACD Hist.+0.1587
BB Upper21.32 USD
BB Middle19.53 USD
BB Lower17.73 USD
BB Width18.37%
ATR (14)0.9362 USD
Vol Ratio (20d)0.71x